9.105USD-3.24%Mkt Cap: 2.31B $P/E: —1d ago
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuramini…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap2.31B $
Enterprise Value2.93B $
Revenue (TTM)885.72M $
Gross Profit855.76M $
Net Income (TTM)263.86M $
Revenue/Share4.059 USD
Last Price9.105 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees435
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS09058V1035
Valuation
P/E (Trailing)—
P/E (Forward)9.84
PEG9.39
EV/EBITDA8.99
EV/Revenue3.31
P/S2.61
P/B-4.18
EPS (TTM)-1.77
EPS (Forward)0.93
52W Range
6.00059% of range11.22
52W High11.22 USD
52W Low6.000 USD
Profitability
Gross Margin97.82%
Oper. Margin-2.45%
EBITDA Margin36.86%
Profit Margin30.16%
ROE-221.45%
ROA51.32%
Growth
Revenue Growth7.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF347.37M $
CapEx (TTM)2.47M $
FCF Margin29.85%
FCF Yield11.42%
Net Debt619.68M $
Net Debt/EBITDA1.90
Balance Sheet
Debt/Equity-3.68
Current Ratio1.91
Quick Ratio1.78
Book Value/Sh-2.1800 USD
Cash/Share0.9380 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.00 USD
Upside (mean)+130.6%
Target Range12.00 USD – 32.00 USD
$12.00+130.6% to mean$32.00
# Analysts11
Ownership
Shares Out.254.16M
Float221.04M
Insiders1.20%
Institutions100.25%
Short Interest
Short Ratio8.4d
Short % Float19.30%
Short % Out.19.16%
Shares Short48.69M
Short (prev mo.)36.65M
Technical
SMA 509.177 (-0.8%)
SMA 2008.109 (+12.3%)
Beta0.54
S&P 52W Chg20.25%
Avg Vol (30d)5.28M
Avg Vol (10d)5.31M
Technical Indicators
RSI (14)44.0
MACD0.1996
MACD Signal0.3083
MACD Hist.-0.1087
BB Upper10.90 USD
BB Middle9.734 USD
BB Lower8.572 USD
BB Width23.87%
ATR (14)0.5205 USD
Vol Ratio (20d)0.57x